Target Selectivity of Ruxolitinib (INCB18424)
| Key Target | IC50 | Description | Reference |
|---|---|---|---|
| Purified JAK2 | 0.003 ng/ml | ADP-Glo kinase-assay kit, steady-state enzyme kinetics | PMC4588578 |
| JAK | 0.4 nM | ATP-binding site inhibition assay | PMC10064968 |
| JAK2 | 2.8 nM | Derived from Table 1, specific assay method not detailed in this text. | PMC12169581 |
| JAK2 | 2.8 nM | Kinase activity assay | PMC9035837 |
| JAK2 | 2.8 nM | Enzyme activity assay | PMC13133158 |
| JAK2 | 3.2 nM | LANCE Ultra kinase assay | PMC11215726 |
| JAK1 | 3.3 nM | Derived from Table 1, specific assay method not detailed in this text. | PMC12169581 |
| JAK1 | 3.3 nM | in vitro studies | PMC6072266 |
| JAK1 | 3.3 nM | Kinase activity assay | PMC9035837 |
| JAK1 | 3.3 nM | Enzyme activity assay | PMC13133158 |
| pSTAT3 | 5.73 nM | pSTAT3 inhibition assay | PMC12014301 |
| JAK1 | 5.8 nM | LANCE Ultra kinase assay | PMC11215726 |
| TYK2 | 19 nM | Derived from Table 1, specific assay method not detailed in this text. | PMC12169581 |
| TYK2 | 19 nM | Kinase activity assay | PMC9035837 |
| JAK2 | 23.66 nM | ADP-Glo™ kinase assay ([Vendor] Corporation), luminescence measurement. | PMC12395164 |
| TYK2 | 60 nM | LANCE Ultra kinase assay | PMC11215726 |
| STAT signaling | 100 nM | cytokine-induced STAT signaling inhibition (cellular assays and animal models) | PMC11938667 |
| JAK3 | 278 nM | LANCE Ultra kinase assay | PMC11215726 |
| JAK3 | 428 nM | Derived from Table 1, specific assay method not detailed in this text. | PMC12169581 |
| JAK3 | 428 nM | in vitro studies | PMC6072266 |
| JAK3 | 428 nM | Kinase activity assay | PMC9035837 |
| ACVR1 | 6100 nM | inhibition of BMP6/ACVR1/SMAD1/5/8-mediated hepcidin expression | PMC11938667 |
Check the
Ruxolitinib (INCB18424)
product page for in-depth specifications, including solubility, stock solutions, MOA, and working concentrations.
Jump to
- Ruxolitinib (INCB18424) Mechanism of Action: JAK1/2 Inhibition in T Lymphocytes Research
- Ruxolitinib (INCB18424) Clinical Trials
- Ruxolitinib (INCB18424) Working Concentration | Cell Culture | Treatment
- Ruxolitinib (INCB18424) Solubility in DMSO
- Ruxolitinib (INCB18424) Storage
- Ruxolitinib (INCB18424) Stability
- Ruxolitinib (INCB18424) Combination Database
- Ruxolitinib (INCB18424) Molecular Weight
- Ruxolitinib (INCB18424) SMILES
- Ruxolitinib (INCB18424) CAS Number
- Ruxolitinib (INCB18424) Chemical Structure (2D and 3D)
- Ruxolitinib (INCB18424) IC50 for Cell-based and Cell-free Assays
- Ruxolitinib (INCB18424) MedChemExpress (HY-50856)? Try a better option.
- Ruxolitinib (INCB18424) Abmole (M3030)? Try a better option.
- Ruxolitinib (INCB18424) Tocris (7064)? Try a better option.
- Ruxolitinib (INCB18424) Cayman (11609)? Try a better option.
- Ruxolitinib (INCB18424) Sigma (AMBH93D5362D)? Try a better option.
- Ruxolitinib (INCB18424) SDS|MSDS